IL-1β enhances cell viability and decreases 5-FU sensitivity in novel colon cancer cell lines derived from African American patients
BackgroundIn the U.S., African Americans (AAs) present with the highest incidence and mortality rates for Colorectal Cancer (CRC). When compared to Caucasian American (CA) patients, AAs also have reduced response to the first line standard of care chemotherapeutic agent 5-Fluorouracil (5-FU). Previo...
Glavni autori: | , , , , , , |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
Frontiers Media S.A.
2022-12-01
|
Serija: | Frontiers in Oncology |
Teme: | |
Online pristup: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1010380/full |